TikoMed
Viken
About TikoMed
They develop and commercialize innovative treatments for patients with severe and life-threatening conditions. Their products have the potential to improve outcomes in the treatment of neurological and opthalmic disease and for ground-breaking regenerative cell therapies. They give hope for patients lacking satisfactory alternatives.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $14.6M
- Last round: Series Unknown (Mar 2020)
- Website: tikomed.com
Industries & Categories
Biotechnology, Therapeutics
Social Profiles
Canonical: https://fsome.com/organization/tikomed-152595 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.